Imagine

BenevolentAI

BenevolentAI uses AI to accelerate biopharma drug discovery and provide life science intelligence.

The AI REPORT pick
Data
Research & Insights
Enterprise Custom
Overview
ABOUT

BenevolentAI (Euronext Amsterdam: BAI) is a company that applies advanced AI to accelerate biopharma drug discovery. Their next-generation platform targets the complex decisions that drive R&D, providing life science intelligence. They build technology in the service of science, bringing together science and technology teams to push AI and machine learning to new limits. They leverage their knowledge graph and proprietary ontologies to support scientists and executives in leveraging cutting-edge AI with confidence and precision.

USE CASE

Research & Insights

KEY FEATURES

AI-driven drug discovery platform; Knowledge graph and proprietary ontologies; Life science intelligence

Meta
Enterprise Custom
Enterprise Custom
β†’ Go to Pricing Page
Enterprise (250+)
Europe

The AI REPORT Picks

Every week, our team highlights tools solving real business problemsβ€”here’s a quick peek.

See All Top AI Tool

Want Weekly AI Insights?